Sherly Mosessian News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesBaden wübergSherly mosessianMathilde bouscaillouGlobal outreach programHeidelberg universityGe healthcare technologies incGe healthcarePatient care solutionsActivation protein inhibitorsOutreach programBusiness wireStrategy evaluation directorPharmaceutical diagnosticsScientific officerMolecular imaging

SOFIE And GE Healthcare Enter Licensing Agreement To Develop FAP PET Radiotracers

SOFIE And GE Healthcare Enter Licensing Agreement To Develop FAP PET Radiotracers
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Baden wübergUnited statesSherly mosessianGe healthcare technologies incGlobal outreach programGe healthcareHeidelberg universityPatient care solutionsOutreach programEvaluation directorPharmaceutical diagnosticsScientific officerMolecular imagingCare technologiesPatients with pancreatic ductal carcinomaText view

SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers
itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.

United statesBaden wübergSherly mosessianHeidelberg universityGlobal outreach programGe healthcareOutreach programEvaluation directorPharmaceutical diagnosticsScientific officerMolecular imaging

First Patient Imaged in SOFIE s 18F-FAPI Phase 2 trial

/PRNewswire/ SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, has dosed and imaged the first patient with.

United statesShadi esfahaniSherly mosessianFrank vallaClinical developmentHeidelberg universityFibroblast activation protein inhibitorNon randomized studyPrincipal investigatorScientific officerColorectal cancerPancreatic ductal adenocarcinomaActivation proteinSofie biosciences

IND granted for FAP targeting therapeutic in SOFIE partnership

/PRNewswire/ SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, will be supporting, through companion.

Xiaoyuan shawn chenSherly mosessianYantai dongcheng pharmaceutical groupDongcheng groupHeidelberg university hospitalHeidelberg universityScientific officerYantai dongcheng pharmaceuticalActivation protein